| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.773 | 3.963 | 6.551 | 6.895 | 8.231 | 7.490 | 15.408 | 12.463 | 23.288 | 25.874 |
| Total Income - EUR | 1.773 | 3.963 | 6.551 | 6.895 | 8.231 | 8.176 | 15.408 | 12.463 | 23.289 | 25.875 |
| Total Expenses - EUR | 6.347 | 11.045 | 10.651 | 11.385 | 12.604 | 9.536 | 11.796 | 11.438 | 17.618 | 22.566 |
| Gross Profit/Loss - EUR | -4.574 | -7.082 | -4.100 | -4.491 | -4.373 | -1.360 | 3.612 | 1.025 | 5.670 | 3.309 |
| Net Profit/Loss - EUR | -4.621 | -7.161 | -4.580 | -4.560 | -4.455 | -1.432 | 3.458 | 900 | 5.437 | 2.529 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medessence S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.171 | 9.388 | 6.250 | 4.592 | 3.797 | 3.151 | 2.521 | 1.967 | 3.321 | 5.357 |
| Current Assets | 444 | 177 | 423 | 677 | 181 | 226 | 608 | 5 | 2.719 | 4.744 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 11 | 11 | 11 | 0 | 10 | 41 | 78 | 0 | 0 | 0 |
| Cash | 433 | 166 | 412 | 677 | 171 | 185 | 530 | 5 | 2.719 | 4.744 |
| Shareholders Funds | -38.229 | -45.000 | -48.819 | -52.483 | -55.921 | -56.294 | -51.587 | -50.848 | -45.256 | -42.475 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 51.844 | 54.566 | 55.493 | 57.752 | 59.899 | 59.671 | 54.717 | 52.819 | 51.296 | 52.609 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Medessence S.r.l.